Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 1 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 20Polycystic Ovary Syndrome 6Infertility 4Neoplasm Metastasis 2Leiomyoma 2is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. 1Patient Acceptance of Health Care 1Ovarian Cysts 1Myofibroma 1Locally Advanced Breast Cancer 1Infertility, Female 1Carcinoma, Ductal 1Breast Neoplasm Malignant Female 1Breast Carcinoma In Situ 1Anovulation 1Abortion, Spontaneous 1

Interventions

ulipristal acetate 9Leuprolide 4Uterine Artery Embolization 3ulipristal 2Tranexamic Acid 2Letrozole 2Bupivacaine 2ferrous sulfate 1elagolix 1dienogest 1cetrorelix 1Vitamin B 6 1Uterine Myomectomy 1Sodium Chloride 1Sirolimus 1Saline Solution 1Rocuronium 1Pregabalin 1Oxytocin 1Naproxen 1Misoprostol 1Mifepristone 1Lidocaine 1Ibuprofen 1Goserelin 1Gonadotropin-Releasing Hormone 1DMAC2L protein, human 1Celecoxib 1Anesthetics, Local 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Leiomyoma × Letrozole × Clear all
NCT06143631 2026-05-20

PLUM

University of California, San Francisco

Phase 4 Recruiting
140 enrolled

Leiomyoma

NCT02470741 2019-11-15

PLUM

University of California, San Francisco

Phase 4 Completed
12 enrolled 7 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡